|
1
|
Ibrahim T, Mercatali L, Casadei R and
Sabbatini R: Clinical manifestation. Osteoncology textbook. Amadori
D, Cascinu S, Conte P and Ibrahim T: Poletto editore; Milan: pp.
258–276. 2010, PubMed/NCBI
|
|
2
|
Ortiz Gómez JA: The incidence of vertebral
body metastases. Int Orthop. 19:309–311. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sciubba DM, Petteys RJ, Dekutoski MB,
Fisher CG, Fehlings MG, Ondra SL, Rhines LD and Gokaslan ZL:
Diagnosis and management of metastatic spine disease. A review. J
Neurosurg Spine. 13:94–108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nielson OS, Munro AJ and Tannock IF: Bone
metastasis: Pathophysiology and management policy. J Clin Oncol.
9:509–524. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
García-Picazo A, Capilla Ramírez P, Pulido
Rivas P and Garcia de Sola R: Utility of surgery in the treatment
of epidural vertebral metastases. Acta Neurochir (Wien).
103:131–138. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bach F, Larsen BH, Rohde K, Børgesen SE,
Gjerris F, Bøge-Rasmussen T, Agerlin N, Rasmusson B, Stjernholm P
and Sørensen PS: Metastatic spinal cord compression. Occurrence,
symptoms, clinical presentations and prognosis in 398 patients with
spinal cord compression. Acta Neurochir (Wien). 107:37–43. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gilbert RW, Kim JH and Posner JB: Epidural
spinal cord compression from metastatic tumor: Diagnosis and
treatment. Ann Neurol. 3:40–51. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wild WO and Porter RW: Metastatic epidural
tumor of the spine. A study of 45 cases. Arch Surg. 87:825–830.
1963. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aoude A, Fortin M, Aldebeyan S, Ouellet J,
Amiot LP, Weber MH and Jarzem P: The revised Tokuhashi score;
analysis of parameters and assessment of its accuracy in
determining survival in patients afflicted with spinal metastasis.
Eur Spine J. 27:835–840. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ibrahim T, Mercatali L and Amadori D: A
new emergency in oncology: Bone metastases in breast cancer
patients (Review). Oncol Lett. 6:306–310. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Patchell RA, Tibbs PA, Regine WF, Payne R,
Saris S, Kryscio RJ, Mohiuddin M and Young B: Direct decompressive
surgical resection in the treatment of spinal cord compression
caused by metastatic cancer: A randomised trial. Lancet.
366:643–648. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Delank KS, Wendtner C, Eich HT and Eysel
P: The treatment of spinal metastases. Dtsch Arztebl Int.
108:71–79. 2011.PubMed/NCBI
|
|
13
|
Jacobs WB and Perrin RG: Evaluation and
treatment of spinal metastases: An overview. Neurosurg Focus.
11:e102001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Markoe AM and Schwade JG: The role of
radiation therapy in the management of spine and spinal cord
tumors. In Spine Tumors. Rea GL: American Association of
Neurological Surgeons; Park Ridge: pp. ILpp23–35. 1994
|
|
15
|
Ryu SI, Chang SD, Kim DH, Murphy MJ, Le
QT, Martin DP and Adler JR Jr: Image-guided hypo-fractionated
stereotactic radiosurgery to spinal lesions. Neurosurgery.
49:838–846. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang SD, Adler J Jr and Hancock S:
Clinical uses of radiosurgery. Oncology (Williston Park).
12:1181-1188–1191-1192. 1998.
|
|
17
|
Shi S, Yang J and Sun D: CT-guided 125I
brachytherapy on pulmonary metastases after resection of colorectal
cancer: A report of six cases. Oncol Lett. 9:375–380. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Lu J, Liu L, Liu T, Chen K, Liu F
and Huang G: Clinical application of CT-guided 125I seed
interstitial implantation for local recurrent rectal carcinoma.
Radiat Oncol. 6:1382011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhongmin W, Yu L, Fenju L, Kemin C and
Gang H: Clinical efficacy of CT-guided iodine-125 seed implantation
therapy in patients with advanced pancreatic cancer. Eur Radiol.
20:1786–1791. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Lu J, Liu T, Chen K, Huang G and
Liu F: CT-guided interstitial brachytherapy of inoperable non-small
cell lung cancer. Lung Cancer. 74:253–257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martínez-Monge R, Pagola M, Vivas I and
López-Picazo JM: CT-guided permanent brachytherapy for patients
with medically inoperable early-stage non-small cell lung cancer
(NSCLC). Lung Cancer. 61:209–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nasser NJ, Sappiatzer J, Wang Y, Borg J
and Saibishkumar EP: Dosimetric evaluation of clinical target
volume in the postimplant analysis of low-dose-rate brachytherapy
for prostate cancer. Brachytherapy. 14:189–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Z, Tan J, Zhao R, Wang J, Sun H, Wang
X, Xu L, Jiang H and Zhang J: Clinical investigations on the spinal
osteoblastic metastasis treated by combination of percutaneous
vertebroplasty and (125)I seeds implantation versus radiotherapy.
Cancer Biother Radiopharm. 28:58–64. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cosset JM, Flam T, Thiounn N, Rosenwald
JC, Pontvert D, Timbert M, Solignac S and Chauveinc L:
Brachytherapy for prostate cancer: Old concept, new techniques.
Bull Cancer. 93:761–766. 2006.(In French). PubMed/NCBI
|
|
26
|
Peretz T, Nori D, Hilaris B, Manolatos S,
Linares L, Harrison L, Anderson LL, Fuks Z and Brennan MF:
Treatment of primary unresectable carcinoma of the pancreas with
I-125 implantation. Int J Radiat Oncol Biol Phys. 17:931–935. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lewis JW Jr, Ajlouni M, Kvale PA, Groux N,
Bae Y, Horowitz BS and Magilligan DJ Jr: Role of brachytherapy in
the management of pulmonary and mediastinal malignancies. Ann
Thorac Surg. 49:728–323. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao F, Li C, Gu Y, Huang J and Wu P:
CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes
recurrence from esophageal carcinoma: Effectiveness and safety in
16 patients. Eur J Radiol. 82:e70–e75. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Potters L, Roach M III, Davis BJ, Stock
RG, Ciezki JP, Zelefsky MJ, Stone NN, Fearn PA, Yu C, Shinohara K
and Kattan MW: Postoperative nomogram predicting the 9-year
probability of prostate cancer recurrence after permanent prostate
brachytherapy using radiation dose as a prognostic variable. Int J
Radiat Oncol Biol Phys. 76:1061–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stock RG, Stone NN, Cesaretti JA and
Rosenstein BS: Biologically effective dose values for prostate
brachytherapy: Effects on PSA failure and posttreatment biopsy
results. Int J Radiat Oncol Biol Phys. 64:527–533. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee WR, Bae K, Lawton CA, Gillin MT,
Morton G, Firat S, Baikadi M, Kuettel M, Greven K and Sandler H: A
descriptive analysis of postimplant dosimetric parameters from
Radiation Therapy Oncology Group P0019. Brachytherapy. 5:239–243.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Marshall RA, Buckstein M, Stone NN and
Stock R: Treatment outcomes and morbidity following definitive
brachytherapy with or without external beam radiation for the
treatment of localized prostate cancer: 20-year experience at Mount
Sinai medical center. Urol Oncol. 32:38.e1–e7. 2014. View Article : Google Scholar
|
|
33
|
Kovtun KA, Wolfsberger L, Niedermayr T,
Sugar EN, Graham PL, Murciano-Goroff Y, Beard C, D'Amico AV, Martin
NE, Orio PF and Nguyen PL: Dosimetric quality and evolution of
edema after low-dose-rate brachytherapy for small prostates:
Implications for the use of newer isotopes. Brachytherapy.
13:152–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saibishkumar EP, Borg J, Yeung I,
Cummins-Holder C, Landon A and Crook J: Sequential comparison of
seed loss and prostate dosimetry of stranded seeds with loose seeds
in 125I permanent implant for low-risk prostate cancer. Int J
Radiat Oncol Biol Phys. 73:61–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saibishkumar EP, Borg J, Yeung I,
Cummins-Holder C, Landon A and Crook JM: Loose seeds vs. stranded
seeds: A comparison of critical organ dosimetry and acute toxicity
in (125)I permanent implant for low-risk prostate cancer.
Brachytherapy. 7:200–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Davis BJ, Horwitz EM, Lee WR, Crook JM,
Stock RG, Merrick GS, Butler WM, Grimm PD, Stone NN, Potters L, et
al: American brachytherapy society consensus guidelines for
transrectal ultrasound-guided permanent prostate brachytherapy.
Brachytherapy. 11:6–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Price JG, Stone NN and Stock RG:
Predictive factors and management of rectal bleeding side effects
following prostate cancer brachytherapy. Int J Radiat Oncol Biol
Phys. 86:842–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Sappiatzer J, Borg J, Rink A and
Saibishkumar EP: Analysis of seed loss and seed displacement and
its dosimetry impact in prostate cancer patients treated with low
dose rate brachytherapy. Med Phys Int. 1 (1 Suppl):S5362013.
|
|
39
|
Cao Q, Wang H, Meng N, Jiang Y, Jiang P,
Gao Y, Tian S, Liu C, Yang R, Wang J and Zhang K: CT-guidance
interstitial (125)Iodine seed brachytherapy as a salvage therapy
for recurrent spinal primary tumors. Radiat Oncol. 9:3012014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sarkar A, Donavanik V, Zhang I, Chen H,
Koprowski C, Hanlon A, Mourtada F, Strasser J and Raben A: Prostate
implant dosimetric outcomes and migration patterns between
bio-absorbable coated and uncoated brachytherapy seeds.
Brachytherapy. 12:356–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rogers CL, Theodore N, Dickman CA, Sonntag
VK, Thomas T, Lam S and Speiser BL: Surgery and permanent 125I seed
paraspinal brachytherapy for malignant tumors with spinal cord
compression. Int J Radiat Oncol Biol Phys. 54:505–513. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Harrison LB, Zelefsky MJ, Armstrong JG,
Schupak KD and Brennan MF: Brachytherapy and function preservation
in the localized management of soft tissue sarcomas of the
extremity. Semin Radiat Oncol. 3:260–269. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
St Clair WH, Arnold SM, Sloan AE and
Regine WF: Spinal cord and peripheral nerve injury: Current
management and investigations. Semin Radiat Oncol. 13:322–332.
2003. View Article : Google Scholar : PubMed/NCBI
|
